Related Experiment Video
Updated: Jun 6, 2025
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.3K
Heterogeneous intratumor irradiation: a new partner for immunotherapy
Paul Bergeron1, Fabien Milliat2, Eric Deutsch1
1INSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Oncoimmunology
|November 26, 2024
Summary
Heterogeneous radiotherapy, combining high and low doses, synergizes with immunotherapy in mice by diversifying immune responses. This approach may improve treatment outcomes when full tumor irradiation is not possible.
Area of Science:
- Oncology
- Radiation Oncology
- Immunotherapy
Background:
- Radiotherapy (RT) and immunotherapy (IO) are key cancer treatments.
- Combining RT and IO can improve therapeutic outcomes.
- Optimizing RT delivery is crucial for maximizing synergy.
Purpose of the Study:
- To investigate the efficacy of a heterogeneous tumor irradiation strategy.
- To explore the combination of high-dose and low-dose RT within the same tumor volume.
- To assess the impact of heterogeneous RT on the antitumor immune response and its synergy with immunotherapy.
Main Methods:
- Utilized a mouse model to test heterogeneous tumor irradiation.
- Administered a combination of high-dose and low-dose radiotherapy.
- Evaluated the synergistic effects with immunotherapy.
- Assessed the spatial diversification of the immune response.
Main Results:
- Heterogeneous tumor irradiation demonstrated synergy with immunotherapy in mice.
- This strategy promoted spatial diversification of the antitumor immune response.
- Heterogeneous RT may enhance the therapeutic index of RT/IO combinations.
Conclusions:
- Heterogeneous tumor irradiation is a promising strategy for enhancing immunotherapy efficacy.
- Spatial fractionation of RT dose can improve the therapeutic index.
- This approach offers potential benefits in clinical scenarios where complete tumor irradiation is challenging.
Related Concept Videos
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
01:30Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340